Oral antiviral drug effective against respiratory syncytial virus (RSV)

An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease.
Read Original Article: Oral antiviral drug effective against respiratory syncytial virus (RSV) »